📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1,000+ announcements match the current filters (relevance ≥ 5).
Sahana System approves ₹125 Cr fundraise via preferential convertible warrants at ₹950/share
Sahana System's Board has approved raising up to ₹125.00 crore through the issuance of 13,15,789 convertible equity warrants at ₹950 per warrant on a preferential basis to non-promoter investors. The proposed fundraise equals approximately 15.6% of the company's current market capitalization (₹801 crore) and ~63% of its net worth (₹198 crore). Four non-promoter entities will subscribe to the warrants, which are convertible into equity shares within 18 months. Additionally, the Board appointed Mr. Ringkesh Jain as an Independent Director for a 5-year term, subject to shareholder approval via postal ballot.
Confidence: HIGH
What changedThe Board approved a ₹125 crore preferential warrant issuance to non-promoter investors and appointed Mr. Ringkesh Jain as an Independent Director.
Why it mattersThe infusion of ₹125 crore substantially bolsters the balance sheet against an existing net worth of ₹198 crore, providing capital to support ongoing expansion in defense-tech, EV infrastructure, and acquisitions.
Total fundraise amount: ₹125,00,00,000Warrant issue price: ₹950Total warrants to be issued: 13,15,789Fundraise vs Market Cap: ~15.6%Conversion tenure: 18 months
📅 Short termMarket sentiment may react positively to the sizable capital raise priced near market price (₹950 vs ₹970.1), while postal ballot approval remains pending until mid-November 2026.
📈 Long termThe capital substantially improves liquidity and growth headroom, though full conversion will lead to equity dilution for existing shareholders over an 18-month horizon.
⚠ Risk flags
- Equity dilution upon warrant conversion
- Shareholder approval required via postal ballot
- Risk of warrant lapse if conversion options are not exercised within 18 months (subject to 25% forfeiture)
Key Highlights
Approved issuance of 13,15,789 convertible equity warrants at ₹950 each to raise ₹125.00 crore
Fundraise represents ~15.6% of current market cap (₹801 Cr) and ~63% of net worth (₹198 Cr)
Issue price of ₹950 is close to the current market price of ₹970.1
Allotted across 4 non-promoter investors, with Magnanimous Trade & Finance taking ₹50 crore (4.36% post-issue)
Postal ballot e-voting scheduled from October 17, 2026, to November 15, 2026
👀 What to Watch
Track the outcome of the postal ballot concluding on November 15, 2026, and monitor subsequent disclosures on warrant allotment and fund deployment towards strategic expansion.
Sahana System approves ₹125 Cr fundraise via preferential convertible warrants at ₹950/share
Sahana System's Board has approved raising up to ₹125.00 crore through the issuance of 13,15,789 convertible equity warrants at ₹950 per warrant on a preferential basis to non-promoter investors. The proposed fundraise equals approximately 15.6% of the company's current market capitalization (₹801 crore) and ~63% of its net worth (₹198 crore). Four non-promoter entities will subscribe to the warrants, which are convertible into equity shares within 18 months. Additionally, the Board appointed Mr. Ringkesh Jain as an Independent Director for a 5-year term, subject to shareholder approval via postal ballot.
Confidence: HIGH
What changedThe Board approved a ₹125 crore preferential warrant issuance to non-promoter investors and appointed Mr. Ringkesh Jain as an Independent Director.
Why it mattersThe infusion of ₹125 crore substantially bolsters the balance sheet against an existing net worth of ₹198 crore, providing capital to support ongoing expansion in defense-tech, EV infrastructure, and acquisitions.
Total fundraise amount: ₹125,00,00,000Warrant issue price: ₹950Total warrants to be issued: 13,15,789Fundraise vs Market Cap: ~15.6%Conversion tenure: 18 months
📅 Short termMarket sentiment may react positively to the sizable capital raise priced near market price (₹950 vs ₹970.1), while postal ballot approval remains pending until mid-November 2026.
📈 Long termThe capital substantially improves liquidity and growth headroom, though full conversion will lead to equity dilution for existing shareholders over an 18-month horizon.
⚠ Risk flags
- Equity dilution upon warrant conversion
- Shareholder approval required via postal ballot
- Risk of warrant lapse if conversion options are not exercised within 18 months (subject to 25% forfeiture)
Key Highlights
Approved issuance of 13,15,789 convertible equity warrants at ₹950 each to raise ₹125.00 crore
Fundraise represents ~15.6% of current market cap (₹801 Cr) and ~63% of net worth (₹198 Cr)
Issue price of ₹950 is close to the current market price of ₹970.1
Allotted across 4 non-promoter investors, with Magnanimous Trade & Finance taking ₹50 crore (4.36% post-issue)
Postal ballot e-voting scheduled from October 17, 2026, to November 15, 2026
👀 What to Watch
Track the outcome of the postal ballot concluding on November 15, 2026, and monitor subsequent disclosures on warrant allotment and fund deployment towards strategic expansion.
Sahana System approves ₹125 Cr fundraise via preferential convertible warrants at ₹950/share
Sahana System's Board has approved raising up to ₹125.00 crore through the issuance of 13,15,789 convertible equity warrants at ₹950 per warrant on a preferential basis to non-promoter investors. The proposed fundraise equals approximately 15.6% of the company's current market capitalization (₹801 crore) and ~63% of its net worth (₹198 crore). Four non-promoter entities will subscribe to the warrants, which are convertible into equity shares within 18 months. Additionally, the Board appointed Mr. Ringkesh Jain as an Independent Director for a 5-year term, subject to shareholder approval via postal ballot.
Confidence: HIGH
What changedThe Board approved a ₹125 crore preferential warrant issuance to non-promoter investors and appointed Mr. Ringkesh Jain as an Independent Director.
Why it mattersThe infusion of ₹125 crore substantially bolsters the balance sheet against an existing net worth of ₹198 crore, providing capital to support ongoing expansion in defense-tech, EV infrastructure, and acquisitions.
Total fundraise amount: ₹125,00,00,000Warrant issue price: ₹950Total warrants to be issued: 13,15,789Fundraise vs Market Cap: ~15.6%Conversion tenure: 18 months
📅 Short termMarket sentiment may react positively to the sizable capital raise priced near market price (₹950 vs ₹970.1), while postal ballot approval remains pending until mid-November 2026.
📈 Long termThe capital substantially improves liquidity and growth headroom, though full conversion will lead to equity dilution for existing shareholders over an 18-month horizon.
⚠ Risk flags
- Equity dilution upon warrant conversion
- Shareholder approval required via postal ballot
- Risk of warrant lapse if conversion options are not exercised within 18 months (subject to 25% forfeiture)
Key Highlights
Approved issuance of 13,15,789 convertible equity warrants at ₹950 each to raise ₹125.00 crore
Fundraise represents ~15.6% of current market cap (₹801 Cr) and ~63% of net worth (₹198 Cr)
Issue price of ₹950 is close to the current market price of ₹970.1
Allotted across 4 non-promoter investors, with Magnanimous Trade & Finance taking ₹50 crore (4.36% post-issue)
Postal ballot e-voting scheduled from October 17, 2026, to November 15, 2026
👀 What to Watch
Track the outcome of the postal ballot concluding on November 15, 2026, and monitor subsequent disclosures on warrant allotment and fund deployment towards strategic expansion.
Sahana System approves ₹125 Cr fundraise via preferential convertible warrants at ₹950/share
Sahana System's Board has approved raising up to ₹125.00 crore through the issuance of 13,15,789 convertible equity warrants at ₹950 per warrant on a preferential basis to non-promoter investors. The proposed fundraise equals approximately 15.6% of the company's current market capitalization (₹801 crore) and ~63% of its net worth (₹198 crore). Four non-promoter entities will subscribe to the warrants, which are convertible into equity shares within 18 months. Additionally, the Board appointed Mr. Ringkesh Jain as an Independent Director for a 5-year term, subject to shareholder approval via postal ballot.
Confidence: HIGH
What changedThe Board approved a ₹125 crore preferential warrant issuance to non-promoter investors and appointed Mr. Ringkesh Jain as an Independent Director.
Why it mattersThe infusion of ₹125 crore substantially bolsters the balance sheet against an existing net worth of ₹198 crore, providing capital to support ongoing expansion in defense-tech, EV infrastructure, and acquisitions.
Total fundraise amount: ₹125,00,00,000Warrant issue price: ₹950Total warrants to be issued: 13,15,789Fundraise vs Market Cap: ~15.6%Conversion tenure: 18 months
📅 Short termMarket sentiment may react positively to the sizable capital raise priced near market price (₹950 vs ₹970.1), while postal ballot approval remains pending until mid-November 2026.
📈 Long termThe capital substantially improves liquidity and growth headroom, though full conversion will lead to equity dilution for existing shareholders over an 18-month horizon.
⚠ Risk flags
- Equity dilution upon warrant conversion
- Shareholder approval required via postal ballot
- Risk of warrant lapse if conversion options are not exercised within 18 months (subject to 25% forfeiture)
Key Highlights
Approved issuance of 13,15,789 convertible equity warrants at ₹950 each to raise ₹125.00 crore
Fundraise represents ~15.6% of current market cap (₹801 Cr) and ~63% of net worth (₹198 Cr)
Issue price of ₹950 is close to the current market price of ₹970.1
Allotted across 4 non-promoter investors, with Magnanimous Trade & Finance taking ₹50 crore (4.36% post-issue)
Postal ballot e-voting scheduled from October 17, 2026, to November 15, 2026
👀 What to Watch
Track the outcome of the postal ballot concluding on November 15, 2026, and monitor subsequent disclosures on warrant allotment and fund deployment towards strategic expansion.
Sahana System approves ₹125 Cr fundraise via preferential convertible warrants at ₹950/share
Sahana System's Board has approved raising up to ₹125.00 crore through the issuance of 13,15,789 convertible equity warrants at ₹950 per warrant on a preferential basis to non-promoter investors. The proposed fundraise equals approximately 15.6% of the company's current market capitalization (₹801 crore) and ~63% of its net worth (₹198 crore). Four non-promoter entities will subscribe to the warrants, which are convertible into equity shares within 18 months. Additionally, the Board appointed Mr. Ringkesh Jain as an Independent Director for a 5-year term, subject to shareholder approval via postal ballot.
Confidence: HIGH
What changedThe Board approved a ₹125 crore preferential warrant issuance to non-promoter investors and appointed Mr. Ringkesh Jain as an Independent Director.
Why it mattersThe infusion of ₹125 crore substantially bolsters the balance sheet against an existing net worth of ₹198 crore, providing capital to support ongoing expansion in defense-tech, EV infrastructure, and acquisitions.
Total fundraise amount: ₹125,00,00,000Warrant issue price: ₹950Total warrants to be issued: 13,15,789Fundraise vs Market Cap: ~15.6%Conversion tenure: 18 months
📅 Short termMarket sentiment may react positively to the sizable capital raise priced near market price (₹950 vs ₹970.1), while postal ballot approval remains pending until mid-November 2026.
📈 Long termThe capital substantially improves liquidity and growth headroom, though full conversion will lead to equity dilution for existing shareholders over an 18-month horizon.
⚠ Risk flags
- Equity dilution upon warrant conversion
- Shareholder approval required via postal ballot
- Risk of warrant lapse if conversion options are not exercised within 18 months (subject to 25% forfeiture)
Key Highlights
Approved issuance of 13,15,789 convertible equity warrants at ₹950 each to raise ₹125.00 crore
Fundraise represents ~15.6% of current market cap (₹801 Cr) and ~63% of net worth (₹198 Cr)
Issue price of ₹950 is close to the current market price of ₹970.1
Allotted across 4 non-promoter investors, with Magnanimous Trade & Finance taking ₹50 crore (4.36% post-issue)
Postal ballot e-voting scheduled from October 17, 2026, to November 15, 2026
👀 What to Watch
Track the outcome of the postal ballot concluding on November 15, 2026, and monitor subsequent disclosures on warrant allotment and fund deployment towards strategic expansion.
Ganesha Ecosphere Subsidiary Secures FSSAI Approval for 4th Food-Grade rPET Line
Ganesha Ecosphere's wholly owned subsidiary, Ganesha Ecopet Private Limited, has received approval from FSSAI for its 4th production line of food-grade rPET (FCM-rPET). The authorized facility is located at Kakatiya Mega Textile Park in Warangal, Telangana, utilizing Starlinger recoSTAR PET technology. The regulatory authorization is valid for a period of 2 years, from October 15, 2026 to October 14, 2028. This allows the company to scale up supplies to food and beverage packaging clients, a segment that has been driving margin expansion.
Confidence: HIGH
What changedGanesha Ecopet Private Limited received formal FSSAI regulatory clearance to produce food-grade rPET on its 4th production line in Telangana.
Why it mattersFood-grade rPET granules command higher realizations than textile-grade chips; getting clearance on the 4th line facilitates commercial scaling for food and beverage packaging clients.
Production Line Approved: 4th production lineApproval Validity Period: 2 years (October 15, 2026 to October 14, 2028)TTM Consolidated Revenue: Rs 1568 Cr
📅 Short termPositive regulatory step removing operational bottlenecks for commercial production from the new line.
📈 Long termSupports the strategic transition from lower-margin recycled fiber toward higher-margin food-grade rPET packaging, aiding operational margins over coming quarters.
⚠ Risk flags
- Approval requires renewal after 2 years (October 14, 2028)
- Scrap bottle price volatility and policy delays in recycled content packaging mandates
Key Highlights
FSSAI approval secured for 4th production line of food-grade rPET at Kakatiya Mega Textile Park, Warangal
Approval granted to wholly owned subsidiary Ganesha Ecopet Private Limited
Authorization is valid for 2 years from October 15, 2026 to October 14, 2028
Authorized to manufacture Food contact material rPET using Starlinger recoSTAR PET technology
👀 What to Watch
Monitor capacity ramp-up and utilization rates for the 4th line in upcoming quarterly disclosures, along with margin contribution from the higher-value food-grade rPET vertical.
Paushak Q2 FY27 PAT Rises 57% YoY to ₹13.51 Cr; Revenue Up 52% YoY to ₹89.32 Cr
Paushak reported strong Q2 FY27 performance with revenue from operations growing 52.0% YoY to ₹89.32 Cr compared to ₹58.78 Cr in Q2 FY26. Profit after tax rose 56.9% YoY to ₹13.51 Cr from ₹8.61 Cr, though it moderated 10.5% sequentially from ₹15.10 Cr in Q1 FY27. For H1 FY27, net profit expanded 38.6% YoY to ₹28.62 Cr on revenue of ₹172.87 Cr. The company's basic EPS for the quarter stood at ₹5.48, and net cash generated from operations strengthened to ₹40.72 Cr in H1 FY27.
Confidence: HIGH
What changedPaushak reported its Q2 and H1 FY27 results, showing over 50% top-line growth driven by higher volume throughput.
Why it mattersDemonstrates commercialization and volume gains from recent downstream capex expansions, re-accelerating profit growth after a muted FY26.
Revenue from Operations (Q2): ₹8,932 lacsProfit After Tax (Q2): ₹1,351 lacsH1 FY27 Revenue: ₹17,287 lacsOperating Cash Flow (H1): ₹4,071.98 lacsH1 Revenue vs TTM Revenue: ~70%
📅 Short termEarnings show strong YoY recovery and top-line momentum, which may be received positively despite slight QoQ net profit contraction.
📈 Long termOperating leverage from the phosgene downstream expansions and 'China Plus One' positioning remains the primary multi-year growth driver.
⚠ Risk flags
- Sequentially lower margins and PAT (QoQ PAT down 10.5%)
- Significant rise in trade receivables to ₹77.18 Cr from ₹54.86 Cr as of March 2026
Key Highlights
Revenue from operations grew 51.96% YoY to ₹8,932 lacs (₹89.32 Cr) in Q2 FY27
Profit after tax increased 56.91% YoY to ₹1,351 lacs (₹13.51 Cr)
H1 FY27 revenue reached ₹17,287 lacs (₹172.87 Cr), up 50.77% YoY
Net cash inflow from operating activities reached ₹4,071.98 lacs in H1 FY27 vs ₹2,468.45 lacs in H1 FY26
Quarterly basic EPS stood at ₹5.48 compared to ₹3.49 in Q2 FY26
👀 What to Watch
Track capacity ramp-up from recent capital expenditure (CWIP reduced to ₹16.16 Cr) and monitor if operating margins hold up against chemical raw material price fluctuations.
Subsidiary DACL Fine Chem Receives APPCB Consent to Establish for Specialty Amines Plant
Diamines & Chemicals Limited announced that its wholly owned subsidiary, DACL Fine Chem Limited, received Consent to Establish (CTE) from the Andhra Pradesh Pollution Control Board on October 15, 2026. The approval is for establishing a proposed plant for Specialty Amines and Chemicals in Kakinada District, Andhra Pradesh. The CTE is valid for 7 years until October 14, 2033. This marks a key regulatory milestone to expand production beyond its existing base, amid Diamines' TTM revenue of ₹41 Cr and TTM net loss of ₹10 Cr.
Confidence: HIGH
What changedWholly owned subsidiary DACL Fine Chem received formal environmental CTE approval to set up a new manufacturing plant in Andhra Pradesh.
Why it mattersEnables the company to begin site construction and setup for specialty amines, essential for broadening its product portfolio and recovering from recent operational losses.
CTE Validity Period: 07 years up to 14/10/2033Approval Date: October 15, 2026Proposed Plant Capex / Capacity: not disclosed
📅 Short termClearance removes initial regulatory hurdles, though immediate financial impact is limited until construction commences.
📈 Long termCould significantly expand manufacturing capacity and support a turnaround if new specialty chemical products achieve commercial viability.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Capex quantum, capacity metrics, and commissioning timelines not disclosed
- Execution and financing risks given negative TTM margins (-23.3%)
Key Highlights
Received Consent to Establish (Order No. 469/APPCB/CTE/RO-KKD/HO/2026) on October 15, 2026
Approval granted by Andhra Pradesh Pollution Control Board (APPCB) for Specialty Amines and Chemicals
Consent validity spans 7 years up to October 14, 2033
Plant location designated across Sy. Nos. 87, 88, 89, 91, and 92 to 102, Thondandi, Kakinada District
👀 What to Watch
Track subsequent capex details, proposed capacity additions, funding mechanisms, and construction timelines for the Kakinada site.
Paushak Q2 FY27 PAT Rises 57% YoY to ₹13.51 Cr; Revenue Up 52% YoY to ₹89.32 Cr
Paushak reported strong Q2 FY27 performance with revenue from operations growing 52.0% YoY to ₹89.32 Cr compared to ₹58.78 Cr in Q2 FY26. Profit after tax rose 56.9% YoY to ₹13.51 Cr from ₹8.61 Cr, though it moderated 10.5% sequentially from ₹15.10 Cr in Q1 FY27. For H1 FY27, net profit expanded 38.6% YoY to ₹28.62 Cr on revenue of ₹172.87 Cr. The company's basic EPS for the quarter stood at ₹5.48, and net cash generated from operations strengthened to ₹40.72 Cr in H1 FY27.
Confidence: HIGH
What changedPaushak reported its Q2 and H1 FY27 results, showing over 50% top-line growth driven by higher volume throughput.
Why it mattersDemonstrates commercialization and volume gains from recent downstream capex expansions, re-accelerating profit growth after a muted FY26.
Revenue from Operations (Q2): ₹8,932 lacsProfit After Tax (Q2): ₹1,351 lacsH1 FY27 Revenue: ₹17,287 lacsOperating Cash Flow (H1): ₹4,071.98 lacsH1 Revenue vs TTM Revenue: ~70%
📅 Short termEarnings show strong YoY recovery and top-line momentum, which may be received positively despite slight QoQ net profit contraction.
📈 Long termOperating leverage from the phosgene downstream expansions and 'China Plus One' positioning remains the primary multi-year growth driver.
⚠ Risk flags
- Sequentially lower margins and PAT (QoQ PAT down 10.5%)
- Significant rise in trade receivables to ₹77.18 Cr from ₹54.86 Cr as of March 2026
Key Highlights
Revenue from operations grew 51.96% YoY to ₹8,932 lacs (₹89.32 Cr) in Q2 FY27
Profit after tax increased 56.91% YoY to ₹1,351 lacs (₹13.51 Cr)
H1 FY27 revenue reached ₹17,287 lacs (₹172.87 Cr), up 50.77% YoY
Net cash inflow from operating activities reached ₹4,071.98 lacs in H1 FY27 vs ₹2,468.45 lacs in H1 FY26
Quarterly basic EPS stood at ₹5.48 compared to ₹3.49 in Q2 FY26
👀 What to Watch
Track capacity ramp-up from recent capital expenditure (CWIP reduced to ₹16.16 Cr) and monitor if operating margins hold up against chemical raw material price fluctuations.
SUPREMEPWR H1 FY27 Net Profit Rises 45% YoY to ₹13.65 Cr; Revenue Up 49% to ₹120.14 Cr
Supreme Power Equipment reported standalone revenue from operations of ₹120.14 Cr for the half year ended September 30, 2026, marking a 48.9% YoY increase compared to ₹80.66 Cr in H1 FY26. Standalone net profit for H1 FY27 surged 45.1% YoY to ₹13.65 Cr from ₹9.41 Cr in the corresponding previous period. Diluted EPS for the half year expanded to ₹5.45 compared to ₹3.76 in H1 FY26. However, consolidated operations utilized net cash of ₹5.74 Cr due to inventory buildup and increased working capital outlays.
Confidence: HIGH
What changedSupreme Power Equipment reported its unaudited standalone and consolidated H1 FY27 financial results showing robust top-line and bottom-line expansion.
Why it mattersThe company continues its strong growth trajectory supported by healthy transformer demand, achieving over 45% of its FY26 full-year revenue within the first half of the year.
Standalone Revenue (H1 FY27): ₹120.14 CrStandalone PAT (H1 FY27): ₹13.65 CrH1 Revenue vs TTM Revenue: ~45.3%Capital Work in Progress: ₹31.91 CrOperating Cash Flow (Consolidated H1): -₹5.74 Cr
📅 Short termStrong top-line and profit growth are likely to support sentiment, though working capital drag and negative operating cash flow remain points to monitor.
📈 Long termSustained execution on order books and expansion of manufacturing capacity (aiming for ₹500-550 Cr revenue potential) underpin multi-year scaling.
⚠ Risk flags
- Negative operating cash flow of -₹5.74 Cr in H1 due to large inventory and receivables absorption
- 100% tender-based business model exposing the firm to state discom payment cycles
Key Highlights
Standalone revenue from operations reached ₹120.14 Cr in H1 FY27, up 48.9% YoY from ₹80.66 Cr in H1 FY26
Standalone profit after tax rose 45.1% YoY to ₹13.65 Cr compared to ₹9.41 Cr in H1 FY26
PBT grew 45.7% YoY to ₹17.88 Cr from ₹12.27 Cr in H1 FY26
Half-year basic EPS improved to ₹5.46 vs ₹3.76 in the corresponding prior period
Consolidated net operating cash flow turned negative at -₹5.74 Cr vs +₹25.90 Cr in full-year FY26 due to working capital expansion
👀 What to Watch
Track conversion of inventory into billings and operating cash flow normalization in H2 FY27, alongside updates on ongoing capex execution (CWIP stood at ₹31.91 Cr).
SUPREMEPWR H1 FY27 Net Profit Rises 45% YoY to ₹13.65 Cr; Revenue Up 49% to ₹120.14 Cr
Supreme Power Equipment reported standalone revenue from operations of ₹120.14 Cr for the half year ended September 30, 2026, marking a 48.9% YoY increase compared to ₹80.66 Cr in H1 FY26. Standalone net profit for H1 FY27 surged 45.1% YoY to ₹13.65 Cr from ₹9.41 Cr in the corresponding previous period. Diluted EPS for the half year expanded to ₹5.45 compared to ₹3.76 in H1 FY26. However, consolidated operations utilized net cash of ₹5.74 Cr due to inventory buildup and increased working capital outlays.
Confidence: HIGH
What changedSupreme Power Equipment reported its unaudited standalone and consolidated H1 FY27 financial results showing robust top-line and bottom-line expansion.
Why it mattersThe company continues its strong growth trajectory supported by healthy transformer demand, achieving over 45% of its FY26 full-year revenue within the first half of the year.
Standalone Revenue (H1 FY27): ₹120.14 CrStandalone PAT (H1 FY27): ₹13.65 CrH1 Revenue vs TTM Revenue: ~45.3%Capital Work in Progress: ₹31.91 CrOperating Cash Flow (Consolidated H1): -₹5.74 Cr
📅 Short termStrong top-line and profit growth are likely to support sentiment, though working capital drag and negative operating cash flow remain points to monitor.
📈 Long termSustained execution on order books and expansion of manufacturing capacity (aiming for ₹500-550 Cr revenue potential) underpin multi-year scaling.
⚠ Risk flags
- Negative operating cash flow of -₹5.74 Cr in H1 due to large inventory and receivables absorption
- 100% tender-based business model exposing the firm to state discom payment cycles
Key Highlights
Standalone revenue from operations reached ₹120.14 Cr in H1 FY27, up 48.9% YoY from ₹80.66 Cr in H1 FY26
Standalone profit after tax rose 45.1% YoY to ₹13.65 Cr compared to ₹9.41 Cr in H1 FY26
PBT grew 45.7% YoY to ₹17.88 Cr from ₹12.27 Cr in H1 FY26
Half-year basic EPS improved to ₹5.46 vs ₹3.76 in the corresponding prior period
Consolidated net operating cash flow turned negative at -₹5.74 Cr vs +₹25.90 Cr in full-year FY26 due to working capital expansion
👀 What to Watch
Track conversion of inventory into billings and operating cash flow normalization in H2 FY27, alongside updates on ongoing capex execution (CWIP stood at ₹31.91 Cr).
Jindal Saw Q2 FY27 Consol PAT Falls 74.5% YoY to ₹35.3 Cr; Order Book at $1,135 Mn
Jindal Saw reported its Q2 FY27 results, showing consolidated revenue growth to ₹4,523.1 crore (up 6.1% YoY from ₹4,264.0 crore), but consolidated PAT dropped sharply by 74.5% YoY to ₹35.3 crore. Standalone EBITDA margin contracted to 6.8% from 9.8% in Q2 FY26, pressured by JJM payment delays and halted MENA exports due to regional conflict. Standalone order book stood at ~$1,135 million (~1.8 million MT) with additional LOIs of ~$575 million. The company is advancing expansions in Abu Dhabi (300,000 TPA seamless pipes) and KSA (600,000 TPA HSAW/LSAW pipes), targeted for FY28-29.
Confidence: HIGH
What changedJindal Saw declared its Q2 FY27 financial performance and provided operational updates on Middle East geopolitical impact and greenfield capex.
Why it mattersOperating margins continue to shrink from oversupply in domestic water infrastructure and disruptions in high-margin Middle East exports, despite stable top-line volumes.
Consolidated Revenue (Q2 FY27): ₹4,523.1 crConsolidated PAT (Q2 FY27): ₹35.3 crStandalone Order Book: ~$1,135 MillionUnexecuted LOIs: ~$575 MillionTax writeback adjustment: ₹26.67 cr
📅 Short termMargin contraction and halted export deliveries to the Middle East may keep market sentiment subdued in the near term.
📈 Long termCapacity additions of 900,000 TPA in UAE and KSA targeting FY29 provide structural long-term growth, contingent on geopolitical stability and project execution.
⚠ Risk flags
- Middle East conflict halting exports and impacting regional operations
- Domestic oversupply and JJM-related payment delays stressing working capital
- Ductile Iron plant in KSA put on hold pending government clarifications
Key Highlights
Consolidated revenue rose 6.1% YoY to ₹4,523.1 crore, but consolidated PAT declined 74.5% YoY to ₹35.3 crore
Standalone EBITDA dropped 20.8% YoY to ₹265.4 crore with margin compressing to 6.8% from 9.8% in Q2 FY26
Order book for pipes and pellets stands at ~$1,135 million (~1.8 million MT), with pending execution spanning 9-12 months
Additional LOIs worth $575 million received, including $430 million of non-MENA export business
Capex updates: 300,000 TPA Abu Dhabi seamless pipe and 600,000 TPA KSA HSAW/LSAW projects scheduled for commercial production in FY28-29
👀 What to Watch
Track the resolution of Middle East export bottlenecks, cash flow recoveries from Jal Jeevan Mission (JJM) receivables, and financial closure milestones for the KEZAD Abu Dhabi facility.
CRISIL Reaffirms Skipper's Rating at 'CRISIL A+/Stable'; Bank Limits Enhanced to ₹5,106 Cr
Skipper Limited received a credit rating reaffirmation from CRISIL Ratings Limited. Long-term bank facilities were reaffirmed at 'CRISIL A+/Stable' with limits enhanced to ₹5,106 Crore from ₹4,621 Crore. Short-term bank facilities were reaffirmed at 'CRISIL A1'. The enhanced limits support the company's expanding working capital and execution needs relative to its TTM revenue of ₹5,609 Crore.
Confidence: HIGH
What changedCRISIL reaffirmed Skipper's long-term and short-term credit ratings while enhancing the total rated bank limit from ₹4,621 Crore to ₹5,106 Crore.
Why it mattersThe reaffirmation confirms financial stability, and the ₹485 Crore enhancement in limits provides additional borrowing and non-fund-based headroom to support ongoing project execution.
Enhanced Long-Term Facilities: Rs.5106 CrorePrevious Long-Term Facilities: Rs.4621 CroreLong-Term Rating: Crisil A+/StableShort-Term Rating: Crisil A1Rated facilities vs TTM revenue: ~91.0%
📅 Short termNeutral operational impact as ratings remain unchanged, ensuring stable borrowing costs and steady banking lines.
📈 Long termLimited structural change; indicates steady balance sheet maintenance and continuous bank support for scale expansion.
⚠ Risk flags
- Higher debt utilization could increase finance costs if working capital cycles stretch.
Key Highlights
CRISIL reaffirmed Long-Term Bank Facilities rating at 'CRISIL A+/Stable'
Long-term rated facilities enhanced by ₹485 Crore to ₹5,106 Crore (from ₹4,621 Crore)
Short-Term Bank Facilities rating reaffirmed at 'CRISIL A1'
👀 What to Watch
Track the upcoming quarterly earnings and working capital cycle to see how effectively the additional bank facilities are utilized to support execution of its transmission and engineering order book.
Jindal Saw Q2 FY27 Standalone PAT at ₹70.69 Cr, Revenue Rises 13.4% YoY to ₹3,823.80 Cr
Jindal Saw reported standalone revenue from operations of ₹3,823.80 crore for Q2 ended September 30, 2026, marking a 13.4% YoY increase from ₹3,371.85 crore in Q2 FY26. Standalone net profit after tax declined 10.8% YoY to ₹70.69 crore (down from ₹79.29 crore), supported by a ₹26.67 crore tax write-back from earlier years. Standalone operating margins compressed sharply to 2.10% from 5.28% in the year-ago period. Separately, the Delhi High Court delivered a split verdict regarding subsidiary Jindal ITF's ₹1,891.08 crore arbitral award, referring it to a third judge.
Confidence: HIGH
What changedJindal Saw announced its Q2 FY27 financial results, reporting operational revenue growth alongside significant margin contraction and an ongoing legal dispute referral.
Why it mattersOperating margins dropped to 2.10%, reflecting continuing cost pressures and inventory movements despite top-line growth across its tubular product segments.
Standalone Revenue (Q2 FY27): ₹3,823.80 crStandalone PAT (Q2 FY27): ₹70.69 crOperating Margin (Q2 FY27): 2.10%Disputed Arbitral Award (Jindal ITF): ₹1,891.08 crCapex Outflow (H1 Consolidated): ₹497.69 cr
📅 Short termWeak operating profitability (2.10% margin) and reliance on tax credits to support bottom line may weigh on short-term market sentiment.
📈 Long termPerformance will hinge on execution of its water and MENA infrastructure order books and successful restoration of double-digit operating margins.
⚠ Risk flags
- Severe contraction in standalone operating margins to 2.10%
- Legal uncertainty regarding subsidiary Jindal ITF's ₹1,891.08 crore arbitral award following a split verdict
Key Highlights
Standalone revenue from operations increased 13.4% YoY to ₹3,823.80 crore in Q2 FY27
Standalone profit before tax fell 58.1% YoY to ₹43.93 crore vs ₹104.75 crore in Q2 FY26
Standalone operating margin shrank to 2.10% in Q2 FY27 from 5.28% in Q2 FY26
Net profit of ₹70.69 crore was aided by ₹26.67 crore prior-period tax adjustments
Subsidiary Jindal ITF's arbitral award of ₹1,891.08 crore received a split verdict, referred to a third judge
👀 What to Watch
Track margin recovery and capacity utilization over upcoming quarters, alongside the legal resolution before the third judge regarding Jindal ITF's ₹1,891.08 crore arbitral award.
Swiggy Completes Sale of Lynks Logistics Stake to Trustroot Internet
Swiggy Limited announced the completion of the sale of its entire shareholding in Lynks Logistics Limited by its wholly owned material subsidiary, Swiggy Networks Limited. The stake was transferred to Trustroot Internet Private Limited at the close of business on October 15, 2026. Consequently, Lynks Logistics ceases to be a step-down subsidiary of Swiggy. The transaction value and financial impact were not disclosed in this filing.
Confidence: HIGH
What changedLynks Logistics Limited has officially ceased to be a step-down wholly owned subsidiary of Swiggy Limited following the completion of its sale.
Why it mattersThe divestment streamlines Swiggy's corporate structure and portfolio, potentially cutting non-core operational drag as it focuses on its primary food delivery and quick commerce segments.
Completion date: October 15, 2026Initial intimation date: September 07, 2026Transaction consideration: not disclosed
📅 Short termLimited near-term price reaction expected as the divestment was previously announced on September 07, 2026, and no financial deal size was provided.
📈 Long termReflects ongoing portfolio pruning to optimize operational focus and allocate capital toward core food delivery and quick commerce (Instamart) expansion.
⚠ Risk flags
- Deal terms and financial consideration not disclosed in the filing
Key Highlights
Sale of entire shareholding in Lynks Logistics Limited completed on October 15, 2026
Buyer identified as Trustroot Internet Private Limited
Lynks Logistics ceases to be a step-down subsidiary of Swiggy Limited
Follows earlier transaction intimation dated September 07, 2026
Financial consideration and deal size were not disclosed in the filing
👀 What to Watch
Track subsequent quarterly financial disclosures for any exceptional gain or loss recognized on the divestment, and monitor management commentary on non-core asset rationalization.
Ujjivan SFB to Raise ₹249.04 Cr via Preferential Equity Issue to IFC at ₹64.73/Share
Ujjivan Small Finance Bank has entered into a subscription agreement and policy agreement with existing shareholder International Finance Corporation (IFC). The bank plans to issue up to 3,84,73,561 equity shares at ₹64.73 each, aggregating to approximately ₹249.04 crore. IFC currently holds 6,21,32,650 shares (3.18% stake) in the bank. The fundraise represents approximately 2.0% of the bank's current market cap of ₹12,490 crore and will strengthen its Tier-1 capital base.
Confidence: HIGH
What changedUjjivan SFB formalized terms to issue fresh equity shares to IFC, raising ~₹249.04 crore and increasing IFC's ownership stake.
Why it mattersThe infusion bolsters the bank's capital adequacy to support loan book expansion, especially across its secured portfolio targets, while validating institutional confidence from a multilateral investor.
Total fundraise value: ~Rs. 249.04 CroresIssue price per share: Rs. 64.73Number of shares to be issued: Up to 3,84,73,561IFC pre-issue holding: 3.18%Fundraise vs Market Cap: ~2.0%
📅 Short termPositive sentiment from IFC expanding its commitment at ₹64.73, which is essentially at the current market price of ₹64.3.
📈 Long termStrengthens capital reserves and supports compliance with ESG and governance frameworks prescribed under IFC's policy agreement.
⚠ Risk flags
- Subject to shareholder and stock exchange in-principle approvals
- Minor equity dilution of existing shareholders
Key Highlights
Preferential issuance of up to 3,84,73,561 equity shares to IFC at an issue price of ₹64.73 per share
Total consideration to be raised aggregates up to ~₹249.04 Crores
IFC holds 6,21,32,650 equity shares (3.18% stake) as of October 15, 2026
Issuance is subject to shareholder approval and in-principle approval from BSE and NSE
👀 What to Watch
Track voting outcome on the shareholder resolution for the preferential issue along with stock exchange in-principle approval timelines.
BLKASHYAP Wins ₹200.02 Cr Commercial Civil Works Order from Nourish Developers
B. L. Kashyap and Sons Limited has secured a domestic civil and structural works order worth ₹200.02 Crores (excluding GST) from Nourish Developers Private Limited. The contract pertains to Phase 3 civil structure works for a commercial building at One DXP, Sector 113, Gurugram, Haryana. The project is scheduled for completion within approximately 25 months. Relative to BLKASHYAP's TTM revenue of ₹1,388 Crores, this single contract represents approximately 14.4% of annual revenue, supporting order book replenishment.
Confidence: HIGH
What changedB. L. Kashyap has added a fresh ₹200.02 Crore civil and structural contract to its order pipeline.
Why it mattersThe order equals ~14.4% of TTM revenue (₹1,388 Cr) and ~31.3% of the company's market cap (₹639 Cr), strengthening forward revenue visibility in its core commercial building vertical.
Order value: ₹ 200.02 CroresExecution timeline: 25 months approx.Order vs TTM revenue: ~14.4%Order vs Market cap: ~31.3%
📅 Short termPositive sentiment driver for the stock as order accretion confirms ongoing commercial real estate demand in NCR (Gurugram).
📈 Long termProvides steady top-line revenue over the next 2+ years, though margin delivery will depend on raw material cost management given historical operating margins of ~7-8%.
⚠ Risk flags
- Execution delays or cost overruns over the 25-month timeline
- Private real estate client concentration risk
Key Highlights
Secured domestic commercial order worth ₹200.02 Crores (excluding GST)
Execution timeline is approximately 25 months
Client: Nourish Developers Private Limited for One DXP, Sector 113, Gurugram
Not a related party transaction; promoter has no interest in awarding entity
Letter of Acceptance (LOA) accepted on 16.10.2026
👀 What to Watch
Track quarterly order inflow trajectory and monitor revenue recognition milestone updates under the Percentage of Completion accounting method over the 25-month execution cycle.
SAL Steel Seeks Approval for Rs 1,050+ Cr Related Party Limits and Prior Loan Ratifications
S.A.L. Steel's Board approved a Postal Ballot notice to seek shareholder ratification and approval for substantial related-party transactions (RPTs) following its takeover by Sree Metaliks Limited (which holds a 57.51% equity stake). Key proposals include post-facto ratification of unsecured loans of Rs 228.67 Cr from Lawrence Merchants and Rs 174.62 Cr of raw material/loan facilities from Sree Metaliks. Additionally, the company is seeking 1-year omnibus approvals for up to Rs 1,050 Cr in transactions with Sree Metaliks (including Rs 500 Cr corporate guarantee and Rs 300 Cr raw material purchases) and Rs 200 Cr loan credit line from Lawrence Merchants. Remote e-voting runs from October 20 to November 18, 2026, with results due by November 20, 2026.
Confidence: HIGH
What changedThe Board approved dispatching a postal ballot notice to regularize historical related-party loans and establish large 1-year operational and financial omnibus limits with its new promoter group.
Why it mattersThe transactions are massive relative to the company's net worth of Rs 147 Cr, reflecting deep operational and balance sheet dependency on new holding entity Sree Metaliks and related lenders.
Lawrence Merchants Loan Ratification: Rs. 228.67 CroreSree Metaliks Facility Ratification: Rs. 174.62 CroreSree Metaliks Corporate Guarantee Limit: Up to Rs. 500 CrSree Metaliks Raw Material Purchase Limit: Up to Rs. 300 CrSree Metaliks Holding Stake: 57.51%Ratified Loans vs Net Worth (Rs 147 Cr): ~274%
📅 Short termShareholders will scrutinize the postal ballot disclosures and voting results ending mid-November 2026, particularly given the retrospective ratification of past borrowings.
📈 Long termOperationally, raw material sourcing arrangements with Sree Metaliks provide supply security for iron ore, but high financial guarantees and related-party financing tie company stability tightly to the promoter group.
⚠ Risk flags
- High volume of post-facto ratifications for material related-party borrowings
- Substantial related-party dependence with holding company Sree Metaliks across raw materials, loans, and guarantees
- Leverage remains elevated relative to net worth
Key Highlights
Post-facto ratification sought for Rs 228.67 Cr loan from Lawrence Merchants and Rs 174.62 Cr trade/loan cap from Sree Metaliks
Omnibus approval proposed for up to Rs 1,050 Cr in aggregate limits with parent Sree Metaliks, including Rs 500 Cr corporate guarantees
Credit line approval of up to Rs 200 Cr from Lawrence Merchants and Rs 150 Cr trade limits with Elite Metaliks
Disclosed that Sree Metaliks now controls a 57.51% equity stake in SAL Steel post-takeover
Remote e-voting scheduled from October 20, 2026, to November 18, 2026; results on or before November 20, 2026
👀 What to Watch
Monitor the outcome of the postal ballot voting concluding on November 18, 2026, and track if public shareholders approve the retrospective and future high-value related-party transactions.
Venus Remedies Secures 5 Marketing Authorisations Across 4 International Markets
Venus Remedies has secured five marketing authorisations across Kazakhstan, Peru, Kuwait, and Argentina. The approved products include critical-care and oncology injectables: Vancomycin and Fluorouracil in Kazakhstan, Fulvestrant in Peru, Methotrexate in Kuwait, and Meropenem in Argentina. These approvals expand the company's existing footprint of over 100 countries across the CIS, Latin America, and Middle East regions. Commercial revenue potential and launch timelines were not disclosed.
Confidence: HIGH
What changedVenus Remedies received regulatory marketing authorisations for 5 injectable formulations across 4 countries (Kazakhstan, Peru, Kuwait, Argentina).
Why it mattersEnables commercial sales of critical care and oncology products in CIS, Latin American, and Middle Eastern markets, supporting international export growth.
Marketing authorisations secured: 5Target countries: 4Existing international footprint: over 100 countriesEstimated financial impact: not disclosed
📅 Short termPositive sentiment for export capabilities, though commercial revenue impact will take time to materialize.
📈 Long termExpands geographic diversification and deepens the penetration of Venus's high-margin injectable portfolio across emerging markets.
⚠ Risk flags
- Commercial uptake and pricing dynamics in target countries remain undisclosed
- Foreign exchange volatility risks on export realizations
Key Highlights
Secured 5 marketing authorisations across 4 international markets
Approvals span Kazakhstan (Vancomycin, Fluorouracil), Peru (Fulvestrant), Kuwait (Methotrexate), and Argentina (Meropenem)
Geographic scope covers CIS, Latin America, and Middle East regions
Adds to company's global footprint spanning over 100 countries
👀 What to Watch
Track the commercial rollout timeline and export revenue contribution from these registrations in upcoming quarterly results.
Modison Q2 FY27 PAT Jumps 100% YoY to Rs 23.29 Cr; Declares Rs 4 Interim Dividend
Modison Limited reported a strong Q2 FY27 consolidated revenue of Rs 279.03 Cr, marking a 92.2% YoY growth compared to Rs 145.16 Cr in Q2 FY26. Consolidated PAT for the quarter doubled (+99.7% YoY) to Rs 23.29 Cr against Rs 11.66 Cr in the year-ago period, though sequential PAT softened 31.2% from Rs 33.84 Cr in Q1 FY27. For H1 FY27, net profit stood at Rs 57.13 Cr compared to Rs 16.47 Cr in H1 FY26. The Board also declared an interim dividend of Rs 4 per share (400% on face value Rs 1) with a record date of October 23, 2026.
Confidence: HIGH
What changedModison reported its Q2 and H1 FY27 results and declared an interim dividend of Rs 4 per share.
Why it mattersDemonstrates sustained top-line scale (>Rs 270 Cr quarterly run rate) compared to FY26 levels, reflecting market share gains in switchgear electrical contacts.
Q2 Consolidated Revenue: Rs 27,902.59 LakhsQ2 Consolidated PAT: Rs 2,328.89 LakhsInterim Dividend per share: Rs 4/-Record Date: October 23, 2026H1 FY27 Revenue vs TTM Revenue: ~65.0%
📅 Short termMarket sentiment should react positively to the 100% YoY profit expansion and healthy interim dividend payout ahead of the October 23 record date.
📈 Long termScale indicates strong industry demand across HV/LV switchgear segments; sustainability hinges on managing raw material inflation and customer concentration.
⚠ Risk flags
- High raw material dependence with raw materials consumed surging to Rs 266.64 Cr
- Sequential contraction in PAT from Rs 33.84 Cr in Q1 FY27 to Rs 23.29 Cr in Q2 FY27
Key Highlights
Q2 FY27 consolidated revenue up 92.2% YoY to Rs 279.03 Cr (vs Rs 145.16 Cr)
Consolidated PAT rose 99.7% YoY to Rs 23.29 Cr from Rs 11.66 Cr in Q2 FY26
H1 FY27 revenue reached Rs 549.49 Cr, up 96.7% YoY from Rs 279.30 Cr
Declared an interim dividend of Rs 4/- per share (400%) with record date October 23, 2026
Basic EPS for Q2 FY27 stood at Rs 7.18 per share vs Rs 3.59 YoY
👀 What to Watch
Track the upcoming Q3 FY27 operational performance and margin trajectory to observe if the elevated raw material costs (Rs 266.64 Cr consumed) compress operating margins.
